Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases

Pietro Speziale1,2, Simonetta Rindi3, Giampiero Pietrocola4

  • 1Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy. pspeziale@unipv.it.

Microorganisms
|March 14, 2018
PubMed

Insights

Antibiotic-resistant Staphylococcus aureus infections necessitate new treatments. This review explores antibody-based therapies, including monoclonal antibodies, for passive immunization against S. aureus.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Staphylococcus aureus is a significant human pathogen causing diverse infections.
  • Antibiotic resistance in S. aureus strains limits treatment options.
  • Alternative therapies are needed due to widespread antibiotic resistance.

Purpose of the Study:

  • To review the development of antibody-based agents against S. aureus.
  • To assess the therapeutic potential of monoclonal antibodies for passive immunization.
  • To update on strategies for treating and preventing S. aureus infections.

Main Methods:

  • Literature review of current research on anti-S. aureus antibodies.
  • Analysis of studies on monoclonal antibody development for S. aureus.
  • Evaluation of passive immunization strategies.

Main Results:

  • Antibody-based therapies are a promising alternative to antibiotics.
  • Monoclonal antibodies show potential for targeted treatment and prevention.
  • Despite controversy, antibodies offer significant host protection against S. aureus.

Conclusions:

  • Antibody-based agents, particularly monoclonal antibodies, represent a viable therapeutic avenue.
  • Passive immunization with antibodies can aid in managing S. aureus infections.
  • Further development is crucial for effective antibody-based treatments against resistant strains.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.6K
Antibiotic Selection00:57

Antibiotic Selection

Overview
60.2K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
652
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
538
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
381